14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
CLSK vs CD: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
CLSK Overall Winner
6-Pillar Tally: CLSK 3 – 2 CD (1 Tie)
Matrix Metrics: CLSK 6 – 4 CD
As of Nov 16, 2026, Cleanspark Inc (CLSK) is the stronger overall head-to-head candidate over CD (CD) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). CLSK carries a Unified Composite Score of 50.7/100 (HOLD) at $6.27 (30.5x Forward P/E, -189.5% operating margin), whereas CD carries 46.1/100 (HOLD) at $3.52 (N/M Forward P/E, -187.2% operating margin).
Growth vs. Quality Trade-Off: CLSK earns the overall head-to-head edge with a stronger Unified Composite Score (50.7/100 HOLD vs. CD 46.1/100 HOLD) and 3.28β · 127% Vol risk profile, whereas CD leads top-line expansion (+98.4% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: CLSK is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.4); meanwhile CD trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 34.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CLSK vs CD. Trailing 12-month operating profitability (CLSK -189.5% vs CD -187.2%) and valuation multiples (CLSK 30.5x vs CD N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Capital Markets value chain with $1.7B market capitalization and -189.5% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
CD Moat ProfileCyclical / Execution-Driven Positioning
Capital Markets Operator
Competes within the Capital Markets value chain with $576.4M market capitalization and -187.2% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ CLSK vs CD Key Questions & Quantitative Answers
As of Nov 16, 2026, Cleanspark Inc (CLSK) is the stronger overall head-to-head candidate over CD (CD) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). CLSK carries a Unified Composite Score of 50.7/100 (HOLD) at $6.27 (30.5x Forward P/E, -189.5% operating margin), whereas CD carries 46.1/100 (HOLD) at $3.52 (N/M Forward P/E, -187.2% operating margin). Growth vs. Quality Trade-Off: CLSK earns the overall head-to-head edge with a stronger Unified Composite Score (50.7/100 HOLD vs. CD 46.1/100 HOLD) and 3.28β · 127% Vol risk profile, whereas CD leads top-line expansion (+98.4% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: CLSK is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.4); meanwhile CD trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 34.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CLSK leads the Growth & Scale pillar: CLSK posts -30.5% YoY revenue growth and +491.6% YoY earnings growth on $679M TTM revenue (47.0% gross margin, -189.5% operating margin), compared with CD at +98.4% YoY revenue growth and +0.0% YoY earnings growth on $2.6M TTM revenue (59.8% gross margin, -187.2% operating margin). On trailing 12-month operating scale, CLSK generates $679M in USD-normalized revenue versus $2.6M for CD. In operating R&D and SG&A reinvestment, CLSK deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for CD.
CLSK screens cheaper on headline valuation multiples. CLSK trades at 30.5x Forward P/E, 30.5x Trailing P/E, N/M PEG, and 4.8x EV/Revenue (unreported FCF margin), whereas CD trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CLSK (-68.6% ROE) versus CD (-7.7% ROE) capital efficiency.
In options market volatility and institutional positioning, CLSK carries 100.6% implied volatility (47th %ile, Balanced (25th–60th %ile)), a 0.66x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (3.28β · 127% Vol realized risk). By comparison, CD carries 126.6% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.59β · 186% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.